Your Input: | |||||
| IL17RD | Interleukin-17 receptor D; Feedback inhibitor of fibroblast growth factor mediated Ras- MAPK signaling and ERK activation. May inhibit FGF-induced FGFR1 tyrosine phosphorylation (By similarity). (741 aa) | ||||
| IL13 | Interleukin-13. (138 aa) | ||||
| IL2 | Interleukin; Belongs to the IL-15/IL-21 family. (143 aa) | ||||
| IL17F | Uncharacterized protein. (169 aa) | ||||
| IL17A | Uncharacterized protein. (169 aa) | ||||
| IL4 | Interleukin 4. (136 aa) | ||||
| IL5 | Interleukin-5; Factor that induces terminal differentiation of late- developing B-cells to immunoglobulin secreting cells. (136 aa) | ||||
| IL3 | Uncharacterized protein. (138 aa) | ||||
| IL17C | Interleukin 17C. (189 aa) | ||||
| IL9 | Interleukin-9. (138 aa) | ||||
| IL17B | Interleukin 17B. (172 aa) | ||||
| KK34 | Uncharacterized protein. (169 aa) | ||||
| LITAF | Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog; Plays a role in endosomal protein trafficking and in targeting proteins for lysosomal degradation. May also contribute to the regulation of gene expression in the nucleus. Binds DNA (in vitro) and may play a synergistic role in the nucleus in regulating the expression of numerous cytokines. (148 aa) | ||||
| IL17RA | SEFIR domain-containing protein. (978 aa) | ||||
| ENSGALP00000071126 | IL17_R_N domain-containing protein. (232 aa) | ||||
| CSF2 | Uncharacterized protein. (144 aa) | ||||
| IL9R | Fibronectin type-III domain-containing protein. (481 aa) | ||||